AHR and arthritic joint disease: Previous research has indicated that butyrate increases the level of AhR ligands (serotonin-derived metabolite 5-Hydroxyindole-3-acetic acid (5-HIAA)) through Regulatory B (Breg) cells dependence and reduces the severity of arthritis (41, 42).